1. A combinatorial biomarker predicts pathologic complete response to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2+ breast cancer. (23rd March 2019) Authors: Veeraraghavan, J; Angelis, C De; Mao, R; Wang, T; Herrera, S; Pavlick, A C; Contreras, A; Nuciforo, P; Mayer, I A; Forero, A; Nanda, R; Goetz, M P; Chang, J C; Wolff, A C; Krop, I E; Fuqua, S A W; Prat, A; Hilsenbeck, S G; Weigelt, B; Reis-Filho, J S Journal: Annals of oncology Issue: Volume 30:Number 6(2019) Page Start: 927 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Addition of biomarker high sensitivity troponin I (hSTROPI) to QRISK3 score in predicting significant coronary artery disease (CAD). (25th November 2020) Authors: Dasari, B.C.A; Oomman, A; Govindarajulu, P; Narra, L; Mao, R; Gunasekaran, S; Satish, S; Showkathali, R; Immaneni, S; Pramodkumar, K.P; Reddy, Y.V.C; Nayak, R Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Calculation of the radiated power in WEST. (14th September 2021) Authors: Devynck, P; Fedorczak, N; Mao, R; Vartanian, S Other Names: collab. Journal: Journal of physics communications Issue: Volume 5:Number 9(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. DOP32 Crohn's disease stricture matrisome analysis reveals the anti-fibrotic activity of milk-fat globule-epidermal growth factor 8 (MFGE8). (30th January 2023) Authors: Lin, S; Wang, J; Mukherjee, P; Mao, R; West, G; Czarnecki, D; Zhao, S; Elias, M; Nguyen, Q T; Chandra, J; Le, T H N; Chen, M H; Dejanovic, D; Holubar, S; Olman, M; Southern, B; Hu, S; Gordon, I O; Atabai, K; Fiocchi, C Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i96 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. DOP62 Efficacy of biologic drugs in short-duration versus long-duration Inflammatory Bowel Disease: A systematic review and an individual-patient data meta-analysis of randomized controlled trials. (21st January 2022) Authors: Ben-Horin, S; Novack, L; Mao, R; Guo, J; Zhao, Y; Sergienko, R; Zhang, J; Kobayashi, K; Hibi, T; Chowers, Y; Peyrin-Biroulet, L; Colombel, J F C; Kaplan, G G K; Chen, M H Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Implementation of multi-component Zhdanov closure in SOLEDGE3X. (1st May 2022) Authors: Bufferand, H; Balbin, J; Baschetti, S; Bucalossi, J; Ciraolo, G; Ghendrih, Ph; Mao, R; Rivals, N; Tamain, P; Yang, H; Giorgiani, G; Schwander, F; Scotto d'Abusco, M; Serre, E; Denis, J; Marandet, Y; Raghunathan, M; Innocente, P; Galassi, D Journal: Plasma physics and controlled fusion Issue: Volume 64:Number 5(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P056 Exposures linked with urban and rural living indicate that living in rural area but spending above 50% of daily-life in urban environment is linked with reduction in alpha-diversity, reduced rural index, and reduced microbial health index mirroring CD profile. (30th January 2023) Authors: Haberman Ziv, Y; Feng, R; Mao, R; Braun, T; Zhuo, S; Toren, I; Efroni, G; Malik, A; Picard, O; Yavzori, M; Hadar, R; Amir, A; Chen, M; Ben-Horin, S Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i222 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P093 Creeping fat-derived long chain free fatty acids drive intestinal muscularis propria muscle cell proliferation via carnitine palmitoyltransferase 1 (CPT-1) – a relevant mechanism for stricturing Crohn's disease. (30th January 2023) Authors: Le, T H N; Mao, R; Liu, W; Czarnecki, D; Chandra, J; Gordon, I O; Plesec, T; Wang, J; Lin, S; Zhao, S; Dejanovic, D; Mukherjee, P; West, G; Fiocchi, C; Brown, J M; Rieder, F Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i255 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P249 Serum calprotectin is useful to confirm Inflammatory Bowel Disease activity but is not effective to predict relapse. (21st January 2022) Authors: Veyrard, P; Roblin, X; Mao, R; Nancey, S; Waeckel, L; Berger, A E; Williet, N; Bastide, L; Barrau, M; Tournier, Q; Paul, S Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i294 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P270 A global consensus on the definitions, diagnosis and management of fibrostenosing small bowel Crohn's disease. (30th January 2023) Authors: Bettenworth, D; Baker, M E; Bemelmann, W; Bruining, D; D'Haens, G; D'Hoore, A; Dignass, A; Dotan, I; Feagan, B G; Feakins, R; Fleshner, P; Fletcher, J G; Gordon, I; Ha, C; Gaylyn, H; Jairath, V; Lu, C; Lyu, R; Ng, S C; Panes, J Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i418 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗